COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

HIV Patients Illness Perception and Adherence

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02276287
Recruitment Status : Completed
First Posted : October 28, 2014
Last Update Posted : October 28, 2014
Sponsor:
Information provided by (Responsible Party):
Daniela Leone, University of Milan

Brief Summary:

Background: the study aimed to explore HIV positive patients' perceptions toward illness and treatment, and their associations with demographic and clinical variables, in particular with adherence.

Methods: the study was conducted at the outpatients clinic of Infectious Disease of a University Hospital in the north of Italy. Patients were asked to fill out the Illness Perception Questionnaire-Revised. Patient's adherence was measured by: viral load (HIV-RNA copies/ml) and presence at the check up.


Condition or disease
HIV

Show Show detailed description

Layout table for study information
Study Type : Observational
Actual Enrollment : 187 participants
Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: HIV Positive Patient's Cognitive and Emotional Illness Perception: a Possible Tool for Understanding Adherence?
Study Start Date : March 2013
Actual Primary Completion Date : April 2014
Actual Study Completion Date : April 2014

Resource links provided by the National Library of Medicine

MedlinePlus related topics: HIV/AIDS




Primary Outcome Measures :
  1. Illness representations [ Time Frame: participants will be followed for the duration of their hospital access, an expected average of 2 hours ]
    Illness Perception Questionnaire Revised (IPQ-R)


Secondary Outcome Measures :
  1. demographic data [ Time Frame: participants will be followed for the duration of their hospital access, an expected average of 2 hours ]
    age, gender, marital status, education, employment status, nationality

  2. clinical data [ Time Frame: from date of HIV diagnosis until the date of the visit in which patients were recruited for the study , assessed from 1984 to 2014 ]
    years diagnosed with HIV, patient history of antiretroviral therapy, years of therapy (first therapy and current therapy), presence of fix dose combination of antiretroviral drugs, current therapeutic regimen's type (once a day and twice a day), total number of pills per day, presence of other drugs' therapies, HIV acquisition risk.

  3. Adherence [ Time Frame: Adherence indexes assessed at the last check up visit (from 2 weeks up to 12 months) ]
    HIV-RNA copies/ml, and presence at the check up visits



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
HIV positive patients recruited at the outpatients clinic of Infectious Disease, S.Paolo University Hospital, Milan, Italy during their check up visit or blood test
Criteria

Inclusion Criteria:

  1. HIV positivity
  2. age ≥18 years
  3. to be able to understand and provide informed consent
  4. to be able to understand a questionnaire in Italian
  5. not to be psychiatric patient
  6. not to be alcohol and/or drugs' abuser

Exclusion Criteria:

  1. not HIV positive patients
  2. age <18 years
  3. inability to understand and provide informed consent
  4. inability to understand a questionnaire in Italian
  5. to be psychiatric patient
  6. to be alcohol and/or drugs' abuser

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02276287


Sponsors and Collaborators
University of Milan
Investigators
Layout table for investigator information
Study Director: Elena Vegni, Professor University of Milan
Layout table for additonal information
Responsible Party: Daniela Leone, PsyD, MS, research fellow, University of Milan
ClinicalTrials.gov Identifier: NCT02276287    
Other Study ID Numbers: UMilan
First Posted: October 28, 2014    Key Record Dates
Last Update Posted: October 28, 2014
Last Verified: October 2014
Keywords provided by Daniela Leone, University of Milan:
Adherence
HAART
HIV
Illness Perception
IPQ-R